# Sinuva

NDC: 10599-003
Generic name: mometasone furoate
Labeler / Manufacturer: Intersect ENT, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: IMPLANT
Routes: INTRASINAL
Marketing started: 20180201

FDA application: NDA209310

## Active ingredients

- MOMETASONE FUROATE: 1350 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10599-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10599-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e33c1b23-cdc6-4f64-94ba-24b0b42c09bf